Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

69.51 +0.54 (+0.78%)
Official Closing Price Updated: 7:00 PM EDT, Apr 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
54 55 Next >
3 Telehealth Stocks With Room to Run in 2024
Embrace 2024's leading telehealth stocks to buy, merging cutting-edge care with smart investing for a lucrative portfolio. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Unpacking the Latest Options Trading Trends in CVS Health
Via Benzinga
3 Top REITs to Strengthen Your Portfolio in Q1
One of the best ways to strengthen your portfolio and generate consistent income is with dependable, top REITs that offer dividends. 
Via InvestorPlace
Hackers Behind MGM Resorts, Caesars Entertainment Security Breach, Targeted UnitedHealth's Prescription Deliveries
Ongoing tech outage at UnitedHealth linked to 'Blackcat' ransomware. Alphabet's cybersecurity unit, Mandiant investigates. 
Via Benzinga
Topics Hacking
Exposures Information Security
Demystifying CVS Health: Insights From 5 Analyst Reviews
Via Benzinga
Check Out What Whales Are Doing With CVS
Via Benzinga
Critical Insights From CVS Health Analyst Ratings: What You Need To Know
Via Benzinga
Is The Economy About To Fall Off The Financial Cliff?
Via Talk Markets
Topics Economy
Exposures Economy
It’s Time! 3 Overplayed REITs to Sell in February
Various REITs are overvalued. Don't hang on to them for too long as serious drawdowns could occur in the following months. 
Via InvestorPlace
Can UnitedHealth Group afford to keep Medicare Advantage plans?
UnitedHealth Group has, to date, been unaffected by the rising costs of Medicare Advantage; investors must decide if that shoe is yet to drop 
Via MarketBeat
3 Cash Cows to Boost Your Confidence During the February Chill
The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns. 
Via InvestorPlace
2008 'Big Short' Oracle Burry Bets Big On Chinese Giants, Backs Google, Amazon's AI Wave
Michael Burry, the visionary investor, made significant changes to his portfolio in Q4 2023. Increased stakes in Chinese retailers and two US tech giants, divested from four companies and reduced... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
CVS Beats Q4 Forecasts with $93.8B Revenue and $2.12 EPS
CVS Health Corp. reported a successful Q4 2023, achieving $93.8 billion in revenue. 
Via Talk Markets
S&P 500 rockets to new highs as earnings beat estimates
The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders. 
Via MarketBeat
Topics ETFs Earnings Stocks
Exposures Financial US Equities
U.S. Weekly Fundflows Insight Report: Equity ETFs, Conventional Funds Suffer Net Redemptions For The Fund-Flows Week
Investors were net sellers of fund assets (including those of conventional funds and ETFs) for the second week in three, redeeming a net $15.7 billion for the LSEG Lipper fund-flows week ended... 
Via Talk Markets
Topics ETFs
What's Going On With Health Insurance Firm UnitedHealth Stock Today?
Explore UnitedHealth Group Inc stock insights! Discover recent market trends, CEO perspectives, and financial highlights. 
Via Benzinga
Earnings Scheduled For February 7, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
Earnings Preview: CVS Health
Via Benzinga
What the Options Market Tells Us About CVS Health
Via Benzinga
CVS Health Unusual Options Activity For February 02
Via Benzinga
The 3 Most Undervalued Stocks With Strong Fundamentals to Buy in February 2024
If you are on the hunt for undervalued stocks, look no further than these three companies with strong fundamentals. 
Via InvestorPlace
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments... 
Via Benzinga
Topics Stocks
Exposures US Equities
CVS Health (CVS) Q4 2023 Earnings Call Transcript
CVS earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
CVS Health's Q4 Earnings Relieve Investor Concerns But Lowers 2024 Profit Guidance Citing Elevated Medical Cost Trends
CVS Health beats Q4 expectations with $2.12 adjusted EPS, allays concerns over healthcare costs. Sales rise 11.9% to $93.81 billion. 
Via Benzinga
Nasdaq, S&P 500 Futures Stall As Rate Worries Dampen Earnings Cheer: Why This Analyst Isn't Worried 'Too Much' About Short-Term Risks
The focus once again shifts to speeches by Federal Reserve officials, as traders seek clarity on the potential schedule for rate cuts. 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
The 3 Most Undervalued S&P 500 Stocks to Buy in February 2024
With undervalued S&P 500 stocks, you get the best of both worlds: the confidence from large-cap companies and a credible bargain. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
The 7 Most Undervalued Large-Cap Stocks to Buy in February 2024
All eyes are on the 'Magnificent Seven," but these seven undervalued large-cap stocks may be worth considering instead. 
Via InvestorPlace
The 3 Most Undervalued Long-Term Stocks to Buy in February 2024
These undervalued stocks for February 2024 are priced for decline, yet they are thriving businesses participating in key growth trends. 
Via InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system. 
Via Benzinga
Topics Economy
Exposures Interest Rates
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
54 55 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.